Bio-Path Holdings reported operational and financial results for the year ended December 31, 2014. In a release on March 17, the Company noted that 2014 OPERATIONAL AND FINANCIAL HIGHLIGHTS include:. -In the fourth quarter of 2014, Bio-Path successfully completed Cohort 6 of its Phase 1 clinical trial evaluating its lead compound, Liposomal Grb-2, in blood…
INN Insider
ACE Introduces ACE Travel Smart
Anthem Blue Cross and Blue Shield in Missouri Rolls Out Doctors Online
Advisor News
- Citi Outlook 2020: Global Growth Can Endure Over The Coming Year
- LPL Financial Launches No-Transaction-Fee, Exchange-Traded Fund Network
- 16 Year-End Financial Planning Tips From The AICPA
- Massachusetts Rule Would Impose Fiduciary Standard For All Advice
- John Hancock Retirement Offers New Stable Value Guaranteed Income Fund
More Advisor NewsAnnuity News
- Commentary: Ned Ryerson Is Just As Cool As Gordon Gekko
- Industry, Consumer Reps Take Final Whack At NAIC Annuity Sales Rule
- MassMutual Study Finds Employers Worried About Employees’ Financial Woes
- Variable Annuities Show Slight Gains In 3Q, Wink Reports
- Best’s: U.S. Life/Annuity Holdings Of Structured Notes On The Rise
More Annuity NewsHealth/Employee Benefits
- Milliman Analysis: Corporate Pension Funding Rises By $15B In November
- Poll: Most In U.S. Still Favor Private Healthcare, But Numbers Falling
- Survey: Most Consumers Satisfied with Their Health Insurance
- A Year After Aetna Purchase, CVS CEO Says Expanded Health Services Coming
- Insurer To Pay $1.8M Penalty For Selling Unapproved Student Health Insurance
More Health/Employee BenefitsLife Insurance
- Florida Man Convicted Of Murdering Wife For Life Insurance
- LIMRA: 3Q Life Insurance Sales Driven By 7% Bump In IUL
- Foresters Financial Updates Underwriting To Cover Pot Smokers
- US Insurance Revenues To Grow 4.3% Annually Through 2023, Report Finds
- Customers Rate Best Life Insurance Companies In Insure.com Survey
More Life Insurance